Literature DB >> 3938400

Fibrinolytic shut-down after surgery: impairment of the balance between tissue-type plasminogen activator and its specific inhibitor.

A D'Angelo, C Kluft, J H Verheijen, D C Rijken, E Mozzi, P M Mannucci.   

Abstract

In nine patients with non-malignant diseases undergoing major upper abdominal surgery, the mechanism of the postoperative fibrinolytic shut-down was investigated because of its potential significance for postoperative deep vein thrombosis by employing new and specific methods for assessing and stimulating the fibrinolytic system. The shut-down was found to result from an impairment of the balance between tissue-type plasminogen activator, t-PA, and its recently discovered fast-acting inhibitor. In this balance, the t-PA antigen concentrations both in resting conditions and after stimulation evoked by desamino-D-arginine vasopressin (DDAVP) were found to be unchanged by surgery. However, there was a significant postoperative increase in t-PA inhibitor levels. The release of t-PA under the stimulus of DDAVP infusion overcame the postoperative shut-down of t-PA activity. However, DDAVP infusion was associated with potentially unfavourable increases in the Factor VIII/von Willebrand factor complex. The discovery of increased t-PA inhibitor in the postoperative period opens new possibilities for a rational approach to reduce or abolish the postoperative fibrinolytic shut-down.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3938400     DOI: 10.1111/j.1365-2362.1985.tb00277.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  13 in total

1.  4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study.

Authors:  Francesco Burzotta; Licia Iacoviello; Augusto Di Castelnuovo; Roberto Zamparelli; Andria D'Orazio; Concetta Amore; Rocco Schiavello; Maria Benedetta Donati; Attilio Maseri; GianFederico Possati; Felicita Andreotti
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

2.  Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. A prospective randomised double-blind placebo-controlled trial.

Authors:  A Planes; N Vochelle; J Y Darmon; M Fagola; M Bellaud; D Compan; E Saliba; N Weisslinger; Y Huet
Journal:  Drugs       Date:  1996       Impact factor: 9.546

Review 3.  Treatment of catastrophic antiphospholipid syndrome.

Authors:  Nayef M Kazzaz; W Joseph McCune; Jason S Knight
Journal:  Curr Opin Rheumatol       Date:  2016-05       Impact factor: 5.006

4.  The Prevalence and Clinical Relevance of ASA Nonresponse After Cardiac Surgery: A Prospective Bicentric Study.

Authors:  Saskia Wand; Elisabeth Hannah Adam; Anna Julienne Wetz; Patrick Meybohm; Nils Kunze-Szikszay; Kai Zacharowski; Aron Frederick Popov; Anton Moritz; Lisa Moldenhauer; Julia Kaiser; Martin Bauer; Christian Friedrich Weber
Journal:  Clin Appl Thromb Hemost       Date:  2017-02-23       Impact factor: 2.389

5.  Postoperative venous thromboembolism and brain tumors: Part III. Biochemical profile.

Authors:  R Sawaya; R F Highsmith
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

6.  Postoperative venous thromboembolism and brain tumors: Part II. Hemostatic profile.

Authors:  R Sawaya; P Glas-Greenwalt
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

Review 7.  The plasminogen-plasmin system in malignancy.

Authors:  H C Kwaan
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

8.  Platelet aggregation and coagulation factors in orthopedic surgery.

Authors:  Brandon S Oberweis; Germaine Cuff; Andrew Rosenberg; Luis Pardo; Michael A Nardi; Yu Guo; Ezra Dweck; Mitchell Marshall; David Steiger; Steven Stuchin; Jeffrey S Berger
Journal:  J Thromb Thrombolysis       Date:  2014-11       Impact factor: 2.300

9.  High PAI activity with correlation to triglyceride and HDL cholesterol values in patients with coronary artery disease with no difference in survivors of myocardial infarction.

Authors:  K Ihnken; W Speiser; W Ruf; W Thiel; M Schlepper; G Müller-Berghaus
Journal:  Ann Hematol       Date:  1993-11       Impact factor: 3.673

10.  PAI-1 and t-PA/PAI-1 complex potential markers of fibrinolytic bleeding after cardiac surgery employing cardiopulmonary bypass.

Authors:  Agnese Ozolina; Eva Strike; Inta Jaunalksne; Angelika Krumina; Lars J Bjertnaes; Indulis Vanags
Journal:  BMC Anesthesiol       Date:  2012-10-30       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.